Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Laurina A. de Jong"'
Autor:
Robert C.A.M. van Waardenburg, Laurina A. de Jong, Foke van Delft, Maria A.J. van Eijndhoven, Melanie Bohlander, Mary-Ann Bjornsti, Jaap Brouwer, Jan H.M. Schellens
Publikováno v:
Molecular Cancer Therapeutics. 3:393-402
Phase I and II clinical trails are currently investigating the antitumor activity of cisplatin and camptothecins (CPTs; DNA topoisomerase I poisons), based on the dramatic synergistic cytotoxicity of these agents in some preclinical models. However,
Autor:
Paul J. Spiess, Christopher A. Klebanoff, Deborah R. Surman, Laurina A. de Jong, David M. Heimann, Florry A. Vyth-Dreese, Willem W. Overwijk, Zhiya Yu, Steven A. Rosenberg, Ada M. Kruisbeek, Steven E. Finkelstein, Douglas C. Palmer, Paul A. Antony, Leroy N. Hwang, Trees A. M. Dellemijn, Nicholas P. Restifo, Lionel Feigenbaum, Marc R. Theoret
Publikováno v:
The Journal of Experimental Medicine
Many tumor-associated antigens are derived from nonmutated “self” proteins. T cells infiltrating tumor deposits recognize self-antigens presented by tumor cells and can be expanded in vivo with vaccination. These T cells exist in a functionally t
Autor:
Robert C.A.M. van Waardenburg, Maria A.J. van Eijndhoven, Lars E.T. Jansen, Caroline Verseyden, Mary-Ann Bjornsti, Dick Pluim, Jan H.M. Schellens, Laurina A. de Jong
Publikováno v:
The Journal of biological chemistry. 279(52)
Camptothecins constitute a novel class of chemotherapeutics that selectively target DNA topoisomerase I (Top1) by reversibly stabilizing a covalent enzyme-DNA intermediate. This cytotoxic mechanism contrasts with that of platinum drugs, such as cispl
Autor:
Robert C A M, van Waardenburg, Laurina A, de Jong, Foke, van Delft, Maria A J, van Eijndhoven, Melanie, Bohlander, Mary-Ann, Bjornsti, Jaap, Brouwer, Jan H M, Schellens
Publikováno v:
Molecular cancer therapeutics. 3(4)
Phase I and II clinical trails are currently investigating the antitumor activity of cisplatin and camptothecins (CPTs; DNA topoisomerase I poisons), based on the dramatic synergistic cytotoxicity of these agents in some preclinical models. However,
Autor:
Jan H.M. Schellens, V. M. M. Herben, Robert C.A.M. van Waardenburg, Jos H. Beijnen, Dick Pluim, Laurina A. de Jong, Nadja E. Schoemaker, Wim W. ten Bokkel Huinink
Publikováno v:
Anti-cancer drugs. 13(1)
Topotecan stabilizes the topoisomerase I (Topo I) cleavable complex. We measured Topo I levels in white blood cells of patients with ovarian cancer treated with topotecan. Topotecan was given i.v. daily x 5 q 3 weeks in combination with paclitaxel (1
Autor:
Laurina A. de Jong, Corline J.A. De Groot, M.M. Schellekens, Catharina B.M. Maassen, Bert A. 't Hart, Jon D. Laman, Marjan van Meurs, Lizette Visser
Publikováno v:
Journal of Neuroimmunology, 119, 124-130. Elsevier
Experimental autoimmune encephalomyelitis (EAE) induced by immunization of mice with epitopes of the proteolipid protein (PLP), a major myelin constituent, forms a useful model for the study of multiple sclerosis (MS). In addition, MS patients displa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01ed0ac2b9116fb98efb2c94e45fd02b
https://pure.eur.nl/en/publications/cc1d15ff-406a-47ff-8ac0-83e5cce05fa3
https://pure.eur.nl/en/publications/cc1d15ff-406a-47ff-8ac0-83e5cce05fa3